...
首页> 外文期刊>American Journal of Physiology >Fibroblast growth factor-23 abolishes 1,25-dihydroxyvitamin D 3-enhanced duodenal calcium transport in male mice
【24h】

Fibroblast growth factor-23 abolishes 1,25-dihydroxyvitamin D 3-enhanced duodenal calcium transport in male mice

机译:成纤维细胞生长因子-23消除了雄性小鼠中1,25-二羟基维生素D 3增强的十二指肠钙转运

获取原文
获取原文并翻译 | 示例

摘要

Despite being widely recognized as the important bone-derived phosphaturic hormone, whether fibroblast growth factor (FGF)-23 modulated intestinal calcium absorption remained elusive. Since FGF-23 could reduce the circulating level of 1,25-dihydroxyvitamin D 3 [1,25(OH) 2D3], FGF-23 probably compromised the 1,25(OH) 2D3 induced intestinal calcium absorption. FGF-23 may also exert an inhibitory action directly through FGF receptors (FGFR) in the intestinal cells. Herein, we demonstrated by Ussing chamber technique that male mice administered 1 ??g/kg 1,25(OH) 2D 3 sc daily for 3 days exhibited increased duodenal calcium absorption, which was abolished by concurrent intravenous injection of recombinant mouse FGF-23. This FGF-23 administration had no effect on the background epithelial electrical properties, i.e., short-circuit current, transepithelial potential difference, and resistance. Immunohistochemical evidence of protein expressions of FGFR isoforms 14 in mouse duodenal epithelial cells suggested a possible direct effect of FGF-23 on the intestine. This was supported by the findings that FGF-23 directly added to the serosal compartment of the Ussing chamber and completely abolished the 1,25(OH) 2D3-induced calcium absorption in the duodenal tissues taken from the 1,25(OH) 2D 3-treated mice. However, direct FGF-23 exposure did not decrease the duodenal calcium absorption without 1,25(OH) 2D 3 preinjection. The observed FGF-23 action was mediated by MAPK/ERK, p38 MAPK, and PKC. Quantitative real-time PCR further showed that FGF-23 diminished the 1,25(OH) 2D3-induced upregulation of TRPV5, TRPV6, and calbindin-D 9k, but not PMCA 1b expression in the duodenal epithelial cells. In conclusion, besides being a phosphatonin, FGF-23 was shown to be a novel calcium-regulating hormone that acted directly on the mouse intestine, thereby compromising the 1,25(OH) 2D 3-induced calcium absorption. ? 2012 the American Physiological Society.
机译:尽管被广泛认为是重要的骨源性磷酸饱和激素,但成纤维细胞生长因子(FGF)-23是否能调节肠道钙的吸收仍不清楚。由于FGF-23可以降低1,25-二羟基维生素D 3 [1,25(OH)2D3]的循环水平,因此FGF-23可能会损害1,25(OH)2D3诱导的肠道钙吸收。 FGF-23还可以直接通过肠细胞中的FGF受体(FGFR)发挥抑制作用。在本文中,我们通过Ussing chamber技术证明,雄性小鼠每天给药1 ?? g / kg 1,25(OH)2D 3 sc 3天,表现出增加的十二指肠钙吸收,并通过同时静脉内注射重组小鼠FGF-23消除。 。施用这种FGF-23对背景上皮的电学性质,即短路电流,跨上皮电位差和电阻没有影响。小鼠十二指肠上皮细胞中FGFR亚型14的蛋白表达的免疫组织化学证据表明,FGF-23可能对肠道有直接作用。 FGF-23直接添加到Ussing室的浆膜隔室并完全废除了从1,25(OH)2D 3取出的十二指肠组织中1,25(OH)2D3诱导的钙吸收,这一发现得到了支持。治疗的小鼠。但是,直接FGF-23暴露并没有减少未注射1,25(OH)2D 3的十二指肠钙的吸收。所观察到的FGF-23作用由MAPK / ERK,p38 MAPK和PKC介导。实时定量PCR进一步显示,FGF-23减少了1,25(OH)2D3诱导的TRPV5,TRPV6和calbindin-D 9k的上调,但未减少十二指肠上皮细胞中PMCA 1b的表达。总而言之,FGF-23除是一种磷酰化处理激素外,还被证明是一种直接作用于小鼠肠道的新型钙调节激素,从而损害了1,25(OH)2D 3诱导的钙吸收。 ? 2012年美国生理学会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号